Compare STN & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STN | BAX |
|---|---|---|
| Founded | 1954 | 1931 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.3B | 9.4B |
| IPO Year | N/A | N/A |
| Metric | STN | BAX |
|---|---|---|
| Price | $95.34 | $18.60 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $25.67 |
| AVG Volume (30 Days) | 232.8K | ★ 8.3M |
| Earning Date | 11-13-2025 | 10-30-2025 |
| Dividend Yield | ★ 0.66% | 0.22% |
| EPS Growth | ★ 44.12 | N/A |
| EPS | ★ 3.04 | N/A |
| Revenue | $4,547,020,941.00 | ★ $11,023,000,000.00 |
| Revenue This Year | $12.18 | $5.20 |
| Revenue Next Year | $10.03 | $2.02 |
| P/E Ratio | $31.18 | ★ N/A |
| Revenue Growth | ★ 12.49 | 3.90 |
| 52 Week Low | $73.18 | $17.40 |
| 52 Week High | $114.52 | $37.74 |
| Indicator | STN | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 32.63 | 43.20 |
| Support Level | $94.14 | $18.33 |
| Resistance Level | $96.10 | $19.17 |
| Average True Range (ATR) | 2.24 | 0.54 |
| MACD | 0.06 | 0.21 |
| Stochastic Oscillator | 19.82 | 63.23 |
Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.